PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 31 filers reported holding PHARMACYTE BIOTECH INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,806 | -70.5% | 40,384 | -59.8% | 0.00% | – |
| Q2 2023 | $287,166 | -39.6% | 100,408 | -38.6% | 0.00% | – |
| Q1 2023 | $475,526 | +35.7% | 163,411 | +36.2% | 0.00% | – |
| Q4 2022 | $350,409 | +74.3% | 120,003 | +43.7% | 0.00% | – |
| Q3 2022 | $201,000 | -19.9% | 83,500 | -24.8% | 0.00% | – |
| Q2 2022 | $251,000 | +217.7% | 111,096 | +222.0% | 0.00% | – |
| Q1 2022 | $79,000 | -20.2% | 34,500 | -12.2% | 0.00% | – |
| Q4 2021 | $99,000 | +45.6% | 39,300 | +84.5% | 0.00% | – |
| Q3 2021 | $68,000 | – | 21,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,061,411 | $2,378,000 | 1.62% |
| Ayrton Capital LLC | 153,130 | $343,000 | 0.56% |
| Shay Capital LLC | 982,698 | $2,201,000 | 0.44% |
| EQUITEC PROPRIETARY MARKETS, LLC | 342,994 | $768,000 | 0.22% |
| FNY Investment Advisers, LLC | 15,290 | $34,000 | 0.02% |
| K2 PRINCIPAL FUND, L.P. | 91,095 | $204,000 | 0.02% |
| Schonfeld Strategic Advisors LLC | 26,200 | $59,000 | 0.00% |
| Aspire Private Capital, LLC | 800 | $2,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,758 | $3,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,734 | $4,000 | 0.00% |